Medicare Enrolled
Dr. Kenneth Blankstein, M.D.
Hematology & Oncology · Flemington, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Blankstein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blankstein?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Blankstein
Dr. Kenneth Blankstein is a hematology & oncology specialist in Flemington, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Blankstein performed 70,640 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Blankstein received a total of $11,733 from 90 pharmaceutical and/or device companies across 436 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Blankstein is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 16% volume in NJ
$11,733 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗70,640
Medicare services
Top 16% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
34,502 | $1 | $4 |
| Anti-nausea injection (aprepitant) | 8,320 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,666 | $18 | $49 |
| Injection, granisetron, extended-release, 0.1 mg | 4,800 | $4 | $15 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
2,772 | $25 | $66 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,524 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,371 | $8 | $51 |
| Injection, leucovorin calcium, per 50 mg | 1,049 | $3 | $24 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
842 | $6 | $27 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
755 | $2 | $13 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
737 | $74 | $229 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
726 | $105 | $323 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
500 | $12 | $127 |
| Anti-nausea injection (ondansetron/Zofran) | 472 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $43 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
419 | $10 | $164 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
410 | $5 | $31 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
365 | $8 | $24 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
320 | $6 | $29 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
300 | $27 | $661 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
270 | $119 | $1,023 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
242 | $72 | $725 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
195 | $12 | $661 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
178 | $2 | $20 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
148 | $30 | $551 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
147 | $60 | $691 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
147 | $2 | $12 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
135 | $19 | $90 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
126 | $7 | $32 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
114 | $5 | $22 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
108 | $19 | $674 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
104 | $68 | $233 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
104 | $1 | $1 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
87 | $24 | $572 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
87 | $1 | $4 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
78 | $31 | $269 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
72 | $22 | $166 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
71 | $69 | $309 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
70 | $159 | $1,102 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
68 | $58 | $497 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
64 | $14 | $145 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
60 | $150 | $518 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 57 | $20 | $99 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
53 | $51 | $416 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
50 | $16 | $79 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
48 | $1 | $11 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
47 | $9 | $43 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
46 | $18 | $123 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
44 | $7 | $57 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
40 | $92 | $420 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $134 | $592 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
32 | $29 | $162 |
| PSA test (prostate cancer screening) | 30 | $18 | $87 |
| New patient office visit, complex (60-74 min) | 25 | $190 | $746 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $96 | $334 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
21 | $1 | $12 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $46 | $157 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $101 | $483 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
16 | $5 | $50 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $144 | $663 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $34 | $110 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
13 | $5 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
50.6% high complexity
42.1% medium
7.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,733
Total received (2018-2024)
Avg $1,676/year across 7 years
Top 24% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
90
Companies
436
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,218
2023
$1,795
2022
$914
2021
$2,725
2020
$2,045
2019
$890
2018
$1,147
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,162
Daiichi Sankyo Inc.
$75
Astellas Pharma US Inc
$70
E.R. Squibb & Sons, L.L.C.
$63
ABBVIE INC.
$62
Lilly USA, LLC
$57
Eisai Inc.
$55
GENZYME CORPORATION
$54
Tempus AI, Inc
$53
GlaxoSmithKline, LLC.
$51
Takeda Pharmaceuticals U.S.A., Inc.
$49
Incyte Corporation
$48
AstraZeneca Pharmaceuticals LP
$40
ARRAY BIOPHARMA INC
$40
BeiGene USA, Inc.
$39
Janssen Biotech, Inc.
$34
SERVIER PHARMACEUTICALS LLC
$33
Rigel Pharmaceuticals, Inc.
$26
SUN PHARMACEUTICAL INDUSTRIES INC.
$24
Genentech USA, Inc.
$22
TAIHO ONCOLOGY, INC.
$21
PFIZER INC.
$19
Janssen Pharmaceuticals, Inc
$19
SpringWorks Therapeutics, Inc.
$19
Kite Pharma, Inc.
$17
Celgene Corporation
$17
Karyopharm Therapeutics Inc.
$17
Adaptive Biotechnologies Corporation
$17
Stemline Therapeutics Inc.
$15
Top 3 companies account for 59.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,951
Novartis Pharmaceuticals Corporation
$1,601
Taiho Oncology, Inc.
$1,326
Janssen Biotech, Inc.
$625
ASD Specialty Healthcare, LLC
$458
Daiichi Sankyo Inc.
$411
E.R. Squibb & Sons, L.L.C.
$313
Astellas Pharma US Inc
$295
Incyte Corporation
$242
PFIZER INC.
$235
Genentech USA, Inc.
$231
Amgen Inc.
$220
Celgene Corporation
$203
GENZYME CORPORATION
$187
Stemline Therapeutics Inc.
$176
Lilly USA, LLC
$156
Takeda Pharmaceuticals U.S.A., Inc.
$148
Eisai Inc.
$121
Janssen Pharmaceuticals, Inc
$117
Kite Pharma, Inc.
$105
Exelixis Inc.
$102
Gilead Sciences, Inc.
$100
Merck Sharp & Dohme Corporation
$99
GlaxoSmithKline, LLC.
$96
GE HEALTHCARE
$92
Pharmacyclics LLC, An AbbVie Company
$82
Bayer HealthCare Pharmaceuticals Inc.
$76
ABBVIE INC.
$75
Foundation Medicine, Inc.
$63
Rigel Pharmaceuticals, Inc.
$59
Regeneron Healthcare Solutions, Inc.
$59
Secura Bio, Inc.
$58
GE HealthCare
$57
BeiGene USA, Inc.
$55
AbbVie Inc.
$55
SERVIER PHARMACEUTICALS LLC
$54
Tempus AI, Inc
$53
ARRAY BIOPHARMA INC
$53
Epizyme, Inc.,
$53
Mirati Therapeutics, Inc.
$50
SUN PHARMACEUTICAL INDUSTRIES INC.
$48
Apellis Pharmaceuticals, Inc.
$48
Seagen Inc.
$47
Alexion Pharmaceuticals, Inc.
$44
Myovant Sciences Inc.
$43
Puma Biotechnology, Inc.
$42
Coherus Biosciences Inc.
$41
Adaptive Biotechnologies Corporation
$39
Covidien LP
$39
TAIHO ONCOLOGY, INC.
$39
AbbVie, Inc.
$36
Heron Therapeutics, Inc.
$35
Servier Pharmaceuticals LLC
$31
Octapharma USA, Inc.
$31
MEDIVATION FIELD SOLUTIONS LLC
$30
PharmaEssentia USA Corporation
$29
EISAI INC.
$29
Ipsen Biopharmaceuticals, Inc
$29
Pharmacyclics LLC, an AbbVie Company
$28
Alnylam Pharmaceuticals Inc.
$27
Boehringer Ingelheim Pharmaceuticals, Inc.
$26
Aveo Pharmaceuticals, Inc.
$25
Verastem, Inc.
$22
CTI BioPharma Corp.
$22
Agios Pharmaceuticals, Inc.
$19
SpringWorks Therapeutics, Inc.
$19
Pharmacosmos Therapeutics Inc.
$18
Karyopharm Therapeutics Inc.
$17
MorphoSys, US Inc.
$17
Ferring Pharmaceuticals Inc.
$17
Innate Pharma, Inc
$17
Nestle HealthCare Nutrition Inc.
$15
Sobi, Inc
$15
TerSera Therapeutics LLC
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Acceleron Pharma, Inc.
$15
Blueprint Medicines Corporation
$15
Sun Pharmaceutical Industries Inc.
$15
PUMA BIOTECHNOLOGY, INC.
$15
ACCORD HEALTHCARE, INC.
$14
Clovis Oncology, Inc.
$14
Jazz Pharmaceuticals Inc.
$14
Spectrum Pharmaceuticals Inc.
$14
EMD Serono, Inc.
$14
Janssen Scientific Affairs, LLC
$14
EUSA Pharma (US) LLC
$14
Array BioPharma Inc.
$13
Roche Diagnostics Corporation
$13
Dova Pharmaceuticals
$12
Teva Pharmaceuticals USA, Inc.
$11
Top 3 companies account for 41.6% of all-time payments
Associated products mentioned in payments ›
ABECMA · AFINITOR · AYVAKIT · Abraxane · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DIS Navify Software · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ENTYVIO · EPKINLY · ERLEADA · EVENITY · Empaveli · Enhertu · Erivedge · Erleada · FARYDAK · FASLODEX · FOTIVDA · FOUNDATIONONE · Farydak · GAZYVA · GILOTRIF · GIVLAARI · GIVLARRI · Halaven · Herceptin · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lumoxiti · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NETSPOT · NINLARO · Neulasta · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO (sonidegib) capsules · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PYRUKYND · Padcev · Pomalyst · REBLOZYL · REBYOTA · RECOTHROM · RETEVMO · ROLVEDON · Reblozyl · Rezlidhia · Rubraca · SARCLISA · SKYRIZI · SOLIRIS · SOMATULINE DEPOT · SUSTOL · SUTENT · Somatuline Depot · Stivarga · SuperDimension · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TRUSELTIQ · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · Voranigo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
81
County median income
$139,453
Nearest hospital to ZIP centroid (approximate)
HUNTERDON MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Blankstein is a mixed practice specialist, with above-average Medicare volume (top 16% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Blankstein experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Blankstein performed 34,502 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Blankstein receive payments from pharmaceutical companies?
Yes. Dr. Blankstein received a total of $11,733 from 90 companies across 436 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blankstein's costs compare to other hematology & oncology specialists in Flemington?
Dr. Blankstein's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blankstein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Flemington
Browse hematology & oncology specialists in Flemington ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Taiho Oncology, Inc. Payments to Doctors
See all physicians who received payments from Taiho Oncology, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology